These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37929730)

  • 1. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
    Singh S; Sachan K; Verma S; Singh N; Singh PK
    Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications.
    Umar H; Wahab HA; Gazzali AM; Tahir H; Ahmad W
    Polymers (Basel); 2022 Jul; 14(15):. PubMed ID: 35956633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Synoptic Update on Smart Lipid Nanocarrier: Cubosomes, and their Design Development, and Recent Challenges.
    Sreelaya P; Bhattacharya S
    Curr Pharm Biotechnol; 2024; 25(4):434-447. PubMed ID: 37211845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.
    Madheswaran T; Kandasamy M; Bose RJ; Karuppagounder V
    Drug Discov Today; 2019 Jul; 24(7):1405-1412. PubMed ID: 31102731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.
    A Vahab S; Nair A; Raj D; G P A; P P S; S Kumar V
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3729-3746. PubMed ID: 38095651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
    Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
    J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
    Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
    J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review.
    Almoshari Y
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds.
    Tan C; Hosseini SF; Jafari SM
    J Agric Food Chem; 2022 Feb; 70(5):1423-1437. PubMed ID: 35089018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cubosomes and hexosomes as versatile platforms for drug delivery.
    Azmi ID; Moghimi SM; Yaghmur A
    Ther Deliv; 2015; 6(12):1347-64. PubMed ID: 26652281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
    Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
    Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
    Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
    Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using
    Pramanik A; Xu Z; Shamsuddin SH; Khaled YS; Ingram N; Maisey T; Tomlinson D; Coletta PL; Jayne D; Hughes TA; Tyler AII; Millner PA
    ACS Appl Mater Interfaces; 2022 Mar; 14(9):11078-11091. PubMed ID: 35196008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles.
    Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
    Int J Pharm; 2016 Dec; 515(1-2):501-505. PubMed ID: 27793711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
    Zhai J; Fong C; Tran N; Drummond CJ
    ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics.
    Gowda BHJ; Ahmed MG; Alshehri SA; Wahab S; Vora LK; Singh Thakur RR; Kesharwani P
    Environ Res; 2023 Nov; 237(Pt 1):116894. PubMed ID: 37586450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size and phase control of cubic lyotropic liquid crystal nanoparticles.
    Hartnett TE; Ladewig K; O'Connor AJ; Hartley PG; McLean KM
    J Phys Chem B; 2014 Jul; 118(26):7430-9. PubMed ID: 24915497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds.
    Dong YD; Larson I; Barnes TJ; Prestidge CA; Boyd BJ
    ACS Appl Mater Interfaces; 2011 May; 3(5):1771-80. PubMed ID: 21506614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cubosomes for topical delivery of the antimicrobial peptide LL-37.
    Boge L; Hallstensson K; Ringstad L; Johansson J; Andersson T; Davoudi M; Larsson PT; Mahlapuu M; Håkansson J; Andersson M
    Eur J Pharm Biopharm; 2019 Jan; 134():60-67. PubMed ID: 30445164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.